© All rights reserved

Home

About Us

Contact

Publications

Research

  Services

 Products

Analytical

PUBLICATIONS
FOR REASONS OF CONFIDENTIALITY WE STILL HAVE SEVERAL UNPUBLISHED REPORTS!

Link to Dr Solomon Habtemariam's  Google Scholar Citations

A: Books

 

1. Basic Chemistry for Life Science Students and Professionals: Introduction to Organic Compounds and Drug Molecules, RSC. 


 

  • Publication Date: 17th May 2023

  • Print ISBN: 978-1-83916-787-4

  • ePub eISBN: 978-1-83916-808-6

Ideal introduction to organic chemistry in the context of the life sciences and pharmacy related disciplines; utilising drug molecules to illustrate their chemical basis of their efficacy   ...

2. Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases

1st Edition

The Chemical and Pharmacological Basis of their Action

  • Paperback ISBN: 9780081022863

  • eBook ISBN: 9780081022948

    Imprint: Elsevier

    Published on: 13th June 2017

    •

  • Price: $225.00 / €210.00 / £180.00

  • By Solomon Habtemariam

    Description

    The African and Arabian Moringa Species: Chemistry, Bioactivity and Therapeutic Applications reviews the botany, socioeconomic significance and underlying chemistry of these interesting plants. The book begins by ...

 

4. Medicinal Plants for Kidney Stone: A Monograph

Medicinal Plants for Kidney Stone: A Monograph
George Varghese, Diana John, Solomon Habtemariam
LAP Lambert Academic Publishing

                 Published on:

2013-12-05                 

Link

ISBN-13:

                  978-3-659-49778-0                    

ISBN-10:

     3659497789     

EAN:

9783659497780

B: Book Chapters

 

  1. HABTEMARIAM, S. (2023). Neuroprotection induced by salvianolic acids. In “Natural molecules in neuroprotection and neurotoxicity. Volume 1”. Edited by de Oliveira, M. R. Academic Press November 24, 2023. pp 1785-1793.

  2. George, K.V., Bose, L.V., HABTEMARIAM, S., Mathew, J. Chapter 3. Premna serratifolia L.: Potential as Nutraceutical Panacea. In: Phytochemicals and Medicinal Plants in Food Design - Strategies and Technologies for Improved Healthcare. Edited by Royal, M.R., Birwal, P., Mishra, S.K. ISBN: 9781771889940. Apple Academic Press.  2022. Pages 71-101.

  3. HABTEMARIAM, S. Chapter 1 - Type-2 diabetes: Definition, diagnosis and significance. In: Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 3-10. https://doi.org/10.1016/B978-0-08-102922-0.00001-8

  4. HABTEMARIAM, S. Chapter 2 - Glucose metabolism: Normal physiology, diabetic dysregulation, and therapeutic targets. In: Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 13-39. https://doi.org/10.1016/B978-0-08-102922-0.00002-X

  5. HABTEMARIAM, S. Chapter 3 - Lipid metabolism: Normal physiology, dysregulation under obesity and diabetes, and therapeutic targets. In: Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 41-65. https://doi.org/10.1016/B978-0-08-102922-0.00003-1

  6.  HABTEMARIAM, S. Chapter 4 - Pathophysiology of type 2 diabetes complications. In: Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 69-88. https://doi.org/10.1016/B978-0-08-102922-0.00004-3

  7.  HABTEMARIAM, S. Chapter 5 - Current pharmacotherapy options for type 2 diabetes. In: Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 89-107. https://doi.org/10.1016/B978-0-08-102922-0.00005-5

  8. HABTEMARIAM, S. Chapter 6 - Introduction to plant secondary metabolites—From biosynthesis to chemistry and antidiabetic action. In: Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 109-132. https://doi.org/10.1016/B978-0-08-102922-0.00006-7

  9. HABTEMARIAM, S. Chapter 7 - Bilberries and blueberries as potential modulators of type 2 diabetes and associated diseases. In: Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 135-175. https://doi.org/10.1016/B978-0-08-102922-0.00007-9

  10. HABTEMARIAM, S. Chapter 8 - The chemical and pharmacological basis of bitter melon (Momordica charantia L.) as a potential therapy for type 2 diabetes and obesity. In: Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 177-249. https://doi.org/10.1016/B978-0-08-102922-0.00008-0

  11. HABTEMARIAM, S. Chapter 9 - The chemical and pharmacological basis of guava (Psidium guajava L.) as potential therapy for type 2 diabetes and associated diseases. In: Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 251-305. https://doi.org/10.1016/B978-0-08-102922-0.00009-2

  12. HABTEMARIAM, S. Chapter 10 - The chemical and pharmacological basis of okra (Abelmoschus esculentus (L.) Moench) as potential therapy for type 2 diabetes. In: Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 307-332. https://doi.org/10.1016/B978-0-08-102922-0.00010-9

  13. HABTEMARIAM, S. Chapter 11 - The chemical and pharmacological basis of papaya (Carica papaya L.) as potential therapy for type-2 diabetes and associated diseases. In: Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 333-363. https://doi.org/10.1016/B978-0-08-102922-0.00011-0

  14. HABTEMARIAM, S. Chapter 12 - The chemical and pharmacological basis of pomegranate (Punica grantum L.) as potential therapy for type-2 diabetes and metabolic syndrome. In: Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 365-433. https://doi.org/10.1016/B978-0-08-102922-0.00012-2

  15. HABTEMARIAM, S. Chapter 13 - The chemical and pharmacological basis of prickly pear cactus (Opuntia species) as potential therapy for type 2 diabetes and obesity. In: Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 435-472

  16. HABTEMARIAM, S. Chapter 14 - The chemical and pharmacological basis of pumpkins (Cucurbita species) as potential therapy for type-2 diabetes. In: Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 473-502. https://doi.org/10.1016/B978-0-08-102922-0.00014-6

  17. HABTEMARIAM, S. Chapter 15 - The chemical and pharmacological basis of cinnamon (Cinnamomum species) as potential therapy for type-2 diabetes and associated diseases. In: Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 505-550. https://doi.org/10.1016/B978-0-08-102922-0.00015-8

  18. HABTEMARIAM, S. Chapter 16 - The chemical and pharmacological basis of cloves (Syzygium aromaticum (L.) Merr. & L.M.Perry) as potential therapy for type 2 diabetes and associated diseases. In Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 551-578. https://doi.org/10.1016/B978-0-08-102922-0.00016-X

  19. HABTEMARIAM, S. Chapter 17 - The chemical and pharmacological basis of fenugreek (Trigonella foenum-graecum L.) as potential therapy for type 2 diabetes and associated diseases. In: Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 579-637. https://doi.org/10.1016/B978-0-08-102922-0.00017-1

  20. HABTEMARIAM, S. Chapter 18 - The chemical and pharmacological basis of ginger (Zingiber officinale Roscoe) as potential therapy for diabetes and metabolic syndrome. In: Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 639-687. https://doi.org/10.1016/B978-0-08-102922-0.00018-3

  21. HABTEMARIAM, S. Chapter 19 - The chemical and pharmacological basis of garlic (Allium sativum L.) as potential therapy for type 2 diabetes and metabolic syndrome. In: Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 689-749. https://doi.org/10.1016/B978-0-08-102922-0.00019-5

  22. HABTEMARIAM, S. Chapter 20 - The chemical and pharmacological basis of turmeric (Curcuma longa L.) as potential therapy for type 2 diabetes and metabolic syndrome. In: Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 751-789. https://doi.org/10.1016/B978-0-08-102922-0.00020-1

  23. HABTEMARIAM, S. Chapter 21 - Chemical and pharmacological evidences for coffee as a modulator of type 2 diabetes and metabolic syndrome. In Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 793-838. https://doi.org/10.1016/B978-0-08-102922-0.00021-3

  24. HABTEMARIAM, S. Chapter 22 - The chemical and pharmacological basis of tea (Camellia sinensis (L.) Kuntze) as potential therapy for type 2 diabetes and metabolic syndrome. In: Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 839-906. https://doi.org/10.1016/B978-0-08-102922-0.00022-5

  25. HABTEMARIAM, S. Chapter 23 - The chemical and pharmacological basis of rooibos (Aspalathus linearis (Burm. F.) R. Dahlgren) as potential therapy for type 2 diabetes and metabolic syndrome. In: Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 907-941. https://doi.org/10.1016/B978-0-08-102922-0.00023-7

  26. HABTEMARIAM, S. Chapter 24 - The chemical and pharmacological basis of yerba maté (Ilex paraguariensis A.St.-Hil.) as potential therapy for type 2 diabetes and metabolic syndrome. In: Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 943-983. https://doi.org/10.1016/B978-0-08-102922-0.00024-9

  27. HABTEMARIAM, S. Chapter 25 - Other common and exotic foods with growing importance as antidiabetic agents. In: Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 985-1047. https://doi.org/10.1016/B978-0-08-102922-0.00025-0

  28. HABTEMARIAM, S. Chapter 26 - Antidiabetic herbal medicines rebranded as dietary supplements. In: Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases - The Chemical and Pharmacological Basis of their Action. 2019, Pages 1049-1134. https://doi.org/10.1016/B978-0-08-102922-0.00026-2

  29. HABTEMARIAM, S. Chapter 1 - Moringa stenopetala—Botanical and Ecological Perspectives. In: The African and Arabian Moringa Species - Chemistry, Bioactivity and Therapeutic Applications. 2017, Pages 3-12. https://doi.org/10.1016/B978-0-08-102286-3.00001-4

  30. HABTEMARIAM, S. Chapter 2 - Moringa stenopetala—Socioeconomic Significance. In: The African and Arabian Moringa Species - Chemistry, Bioactivity and Therapeutic Applications. 2017, Pages 13-29. https://doi.org/10.1016/B978-0-08-102286-3.00002-6

  31.  HABTEMARIAM, S. Chapter 3 - The Chemistry of Moringa stenopetala Seed Oils. In: The African and Arabian Moringa Species - Chemistry, Bioactivity and Therapeutic Applications. 2017, Pages 33-48. https://doi.org/10.1016/B978-0-08-102286-3.00003-8

  32. HABTEMARIAM, S. Chapter 4 - The Chemistry of Moringa stenopetala—Nonoil Components. In: The African and Arabian Moringa Species - Chemistry, Bioactivity and Therapeutic Applications. 2017, Pages 49-58. https://doi.org/10.1016/B978-0-08-102286-3.00004-X

  33. HABTEMARIAM, S. Chapter 5 - Quality Control and Chemical Profiling of Moringa stenopetala. In: The African and Arabian Moringa Species - Chemistry, Bioactivity and Therapeutic Applications. 2017, Pages 59-88. https://doi.org/10.1016/B978-0-08-102286-3.00005-1

  34. HABTEMARIAM, S. Chapter 6 - The Pharmacology of Moringa stenopetala: Toxicology Aspects. In: The African and Arabian Moringa Species - Chemistry, Bioactivity and Therapeutic Applications. 2017, Pages 91-97. https://doi.org/10.1016/B978-0-08-102286-3.00006-3

  35. HABTEMARIAM, S. Chapter 7 - The Pharmacology of Moringa stenopetala—Antioxidant Mechanisms. In: The African and Arabian Moringa Species - Chemistry, Bioactivity and Therapeutic Applications. 2017, Pages 99-115. https://doi.org/10.1016/B978-0-08-102286-3.00007-5

  36. HABTEMARIAM, S. Chapter 8 - The Pharmacology of Moringa stenopetala: Antimicrobial Effects. In: The African and Arabian Moringa Species - Chemistry, Bioactivity and Therapeutic Applications. 2017, Pages 117-123. https://doi.org/10.1016/B978-0-08-102286-3.00008-7

  37. HABTEMARIAM, S. Chapter 9 - The Pharmacology of Moringa stenopetala—Effects on Diabetes and Associated Diseases. In: The African and Arabian Moringa Species - Chemistry, Bioactivity and Therapeutic Applications. 2017, Pages 125-142. https://doi.org/10.1016/B978-0-08-102286-3.00009-9

  38. Chapter 10 - The Pharmacology of Moringa stenopetala—Potential Anticancer Effects. In: The HABTEMARIAM, S. African and Arabian Moringa Species - Chemistry, Bioactivity and Therapeutic Applications. 2017, Pages 143-154. https://doi.org/10.1016/B978-0-08-102286-3.00010-5

  39.  HABTEMARIAM, S. Chapter 11 - The Science Behind the Use of Moringa stenopetala Seeds for Water Purification. In: The African and Arabian Moringa Species - Chemistry, Bioactivity and Therapeutic Applications. 2017, Pages 155-165. https://doi.org/10.1016/B978-0-08-102286-3.00011-7

  40. HABTEMARIAM, S. Chapter 12 - Moringa peregrina (Forssk.) Fiori.: Chemistry, Pharmacology, and Socioeconomic Significance. In: The African and Arabian Moringa Species - Chemistry, Bioactivity and Therapeutic Applications. 2017, Pages 169-192. https://doi.org/10.1016/B978-0-08-102286-3.00012-9

  41. HABTEMARIAM, S. Chapter 13 - Other Moringa Species Endemic to Africa. In: The African and Arabian Moringa Species - Chemistry, Bioactivity and Therapeutic Applications. 2017, Pages 193-207. https://doi.org/10.1016/B978-0-08-102286-3.00013-0

  42. Nabavi, S.F., HABTEMARIAM, S., Nabavi, S.M. (2012). Book (MEDICINAL PLANTS AS ANTIOXIDANT AGENTS: UNDERSTANDING THEIR MECHANISM OF ACTION AND THERAPEUTIC EFFICACY; Edited by Anna Capasso) Chapter: Ferula gummosa Boiss as a rich source of natural antioxidants with numerous therapeutic uses - a short review. Kerala, India. pp. 15–26. ISBN: 978-81-308-0509-2.

 

C: Edited BOOKS & Special ISSUES

 

  1. Nabavi, S.M., Sureda, A., HABTEMARIAM, S. (2022). Special issue edition “The biochemistry and molecular biology of COVID-19”. Chemico-Biological Interaction. Link

  2. Lentini, G., Cavalluzzi, M.M., HABTEMARIAM, S. (2021). Special Issue "Biologically Active Small Molecules Inspired by Plant Secondary Metabolites". Molecules 2021 - Link - Certificate

  3. HABTEMARIAM, S. (2020). Special Issue "Targeting Coronavirus Diseases by Synthetic Chemical Entities and Natural Products".  Molecules 2020:  Link - Certificate

  4. HABTEMARIAM, S.  (2020). Special Issue "The Gut Microbiota as Potential Therapeutic Targets for Synthetic Chemical Entities and Natural Products.  Molecules 2020:  Link - Certificate

  5.  HABTEMARIAM, S. (2019). Special Issue "Natural Products in Alzheimer’s Disease Drug Discovery". Molecules 2019: Link  - Certificate 

  6.  HABTEMARIAM, S. (2019). Special Issue: "Modulation of Reactive Oxygen Species in Health and Disease". Antioxidants 2019: https://www.mdpi.com/journal/antioxidants/special_issues/Reactive_Oxygen. Certificate 

  7.  Roy, B., Newton, A., HABTEMARIAM, S., Hekmatdoost, A., Desai, G.  (2017/18). “INFLAMMATORY BOWEL DISEASE.” eBOOK – Open Access. ISBN: 978-93-87500-06-8. http://openaccessebooks.com/inflammatory-bowel-disease.html.  

  8.  HABTEMARIAM, S., Lentini, G. (2017). Special Issue "Plant Derived Biomedicines".  Biomedicines 2017: Link - Certificate

  9. HABTEMARIAM, S., Lentini, G. (2017). Special Issue: "Plant Polyphenols as Potential Therapeutic Agents for Diabetes and Obesity". Section "Natural Products". Molecules 2017:   Link -  Certificate  

  10. Chaves, R., de Oliveria, W.F., Capone, P., Goimes, E.T., Silve, O.D., Valennzuela-Zapata, A.G., Agostinho, A.B., HABTEMARIAM, S., Pinto, E. PROCEEDINGS LISBON 2010 - Rev 2 – copia. Publisher: Friends the University for Peace Foundation and Faculty of Pharmacy, University of Lisbon. ISBN: 978-989-20-2789-0

 

D: Major Peer Review Journals

 

Full Text Articles Access - Password Required

  1. Hepokur, C., Misir, S., Cicek,  M., HABTEMARIAM, S., Sharifi-Rad J. (2024). Protective Effect of Salvia cadmica on fibroblast cells from t-bhp induced oxidative damage. Current Pharmaceutical Analysis. Published online on 08 April 2024. Abstract  

  2. Reyes-Hernández, O.D., Figueroa-González, G., Quintas-Granados, L.I., Hernández-Parra, H., Peña-Corona, S.I., Cortés, H., Kipchakbayeva, A., Mukazhanova, Z., HABTEMARIAM, S., Leyva-Gómez, G., Büsselberg, D., Sharifi-Rad, J. (2024). New insights into the anti-cancer therapeutic potential of icaritin and its synthetic derivatives.  Drug Development Research. Published online on 3 April 2024. Abstract

  3. Figueroa-Gonzalez, G.,Quintas-Granados, L.I., Reyes-Hernández, O.D., Caballero-Floran,  I.H., Pena-Corona,  S.I., Cortes,  H., Leyva-Gomez,  G., HABTEMARIAM,   S.,  Sharifi-Rad, J. (2024). Review of the anticancer properties of 6-shogaol: Mechanisms of action in cancer cells and future research opportunities.  Food Science & Nutrition – Early view version freely available online from  27 March 2024.  FULL TEXT  

  4. Elsaman, T., Muddathir, A.M., Mohieldin, E.A.M.,   Batubara, I., Rahminiwati, M., Yamauchi, K., Mohamed, M.A.,  Asoka, S. F., Büsselberg, D.,  HABTEMARIAM,  S.,  Sharifi-Rad, J. (2024). Ginsenoside Rg5 as an anticancer drug: a comprehensive review on mechanisms, structure–activity relationship, and prospects for clinical advancement. Pharmacological Report. Published online on 25 March 2024. Abstract

  5. Bhuia, M.S., Chowdhury, R., Ara, I., Mamun, M., Rouf, R., Khan, M.A., Uddin, S.J., Shakil, M.A.K., HABTEMARIAM, S., Ferdous, J., Calina, D., Sharifi-Rad, J., Islam, M.T. (2024). Bioactivities of morroniside: A comprehensive review of pharmacological properties and molecular mechanisms. Fitoterapia. Published online on 11 March 2024. Abstract; Free 80 days FULL TEXT Access

  6. Amini, K., Sahebnasagh, A., Amini, R., HABTEMARIAM, S., Najmeddin, F., Mojtahedzadeh, M. (2024). High dose of vitamin C in septic and critically ill patients with COVID-19: A narrative review. Journal of Nutrition and Food Security 9(1). Published online on 03 February 2024. Abstract

  7.  Ali, M.A., Khan, N., Ali, A., Akram, H., Zafar, N., Imran, K., Khan, T., Khan, K., Armaghan, M., Palma- Morales, M., Rodríguez-Pérez, C., Caunii, A., Butnariu, M., HABTEMARIAM, S., Sharifi-Rad, J. (2024). Oridonin from Rabdosia rubescens: An emerging potential in cancer therapy – A comprehensive review. Food Science & Nutrition, Published online on 01 February 2024. FULL TEXT

  8. Ijaz, S., Iqbal, J., Abbasi, B.A., Tufail, A., Yaseen, T., Uddin, S., Usman, K., Ullah, R., Bibi, H., Inam, P., Sagindykova, E., Gürer, E.S., HABTEMARIAM, S., Calina, D., Sharifi-Rad J. (2024). Current stage of preclinical and clinical development of guggulsterone in cancers: Challenges and promises. Cell Biology International 48(2), 124-142.    Abstract  

  9. Orouji, N., Asl, S.K., Taghipour, Z. HABTEMARIAM, S., Nabavi S.M., Rahimi, R. (2023). Glucosinolates in cancer prevention and treatment: experimental and clinical evidence. Med Oncol 40, 344 (2023). Abstract

  10. Zafar, S., Armaghan, M., Khan, K., Hassan, N., Sharifi-Rad, J., HABTEMARIAM, S., Kieliszek, M., Butnariu, M., Bagiu, I.-C., Bagiu, R.V., Cho, W. C. (2023). New insights into the anticancer therapeutic potential of maytansine and its derivatives. Biomedicine & Pharmacotherapy 165, 115039.  Published online  - September 2023.  FULL TEXT

  11. Peña-Corona, S.I.; Hernández-Parra H.; Bernal-Chávez S.A.; Mendoza-Muñoz N.; Romero-Montero A.; Del Prado-Audelo M.L.; Cortés H.; Ateşşahin D.A.; HABTEMARIAM, S.; Almarhoon Z.M.; Razis A.A.F.; Modu B.; Sharifi-Rad J.; Leyva-Gómez G. (2023). Neopeltolide and its synthetic derivatives: a promising new class of anticancer agents.   Frontiers in Pharmacology 14, Available online from 6 June 2023. FULL TEXT  

  12. Islam, M.T.; Sarkar, C.; Hossain, R.; Bhuia, M.S.; Mardare, I.; Kulbayeva, M.; Ydyrys, A.; Calina, D.; HABTEMARIAM, S.; Kieliszek, M.; Sharifi-Rad, J.; Cho, W.C.  (2023). Therapeutic strategies for rheumatic diseases and disorders: targeting redox imbalance and oxidative stress.  Biomedicine & Pharmacotherapy, 164, 2023. Available online from 20 May 2023. FULL TEXT

  13.  Posadino, A.M.; Giordo, R.; Pintus, G.; Mohammed, S.A.; Orhan, I.E.; Fokou, P.V.T.; Sharopov, F.; Adetunji, C.O.; Gulsunoglu-Konuskan, Z.; Ydyrys, A.; Armstrong, L.; Sytar, O.; Martorell, M.; Razis, A.F.A.; Modu, B.; Calina, D.; HABTEMARIAM, S.; Sharifi-Rad, J.; Cho, W.C. (2023). Medicinal and mechanistic overview of artemisinin in the treatment of human diseases. Biomedicine & Pharmacotherapy, 163, 2023. Available online from 12 May 2023. FULL TEXT

  14. Posadino, A.M.; Giordo, R.; Ramli, I.; Zayed, H.; Nasrallah, G.K.; Wehbe, Z.; Eid, A.H.; Gürer, E.S.; Kennedy, J.F.; Aldahish, A.A.; Calina, D.; Rrazis, A.F.A.; Modu, B.; HABTEMARIAM, S.; Sharifi-Rad, J.; Pintus, G.; Cho, W.C.; (2023).  An updated overview of cyanidins for chemoprevention and cancer therapy, Biomedicine & Pharmacotherapy, 163, 2023, Available online from 28 April 2023. FULL TEXT

  15. Hadeiy, S.K.; Habtemariam, S., Shankayi, Z.; Shahyad, S.; Sahraei, H.; Rezaei, M.A.;   Bahrami, F. (2023). Amelioration of pain and anxiety in sleep-deprived rats by intra-amygdala injection of cinnamaldehyde, Sleep Medicine: X, 5, Available online 23 March 2023. FULL TEXT

  16. Sayyadi, S.; Kashani, H.R.K.; Jafari, R.; Azhari, S.; Salimi, S.; Komlakh, K.; Alesaadi, M.; Alizade, P.; HABTEMARIAM, S.; Khayatkashani, M. (2023). Predictive value of blood markers in nonfunctional pituitary adenomas using artificial neural network. Advanced Biomedical Research.   12, 83.  FULL TEXT

  17. HABTEMAIAM, S. (2023). Anti-inflammatory therapeutic mechanisms of natural products: Insight from Rosemary diterpenes, carnosic acid and carnosol.  Biomedicines  11(2), 545. FULL TEXT of PDF

  18. HABTEMAIAM, S. (2023). The molecular pharmacology of phloretin: Anti-inflammatory mechanisms of action.  Biomedicines 11(1), 143.  Full Text  or PDF

  19. Shirani, M., Vasei, Z., Sedehi, M., Mohammadi, S., Bijad, E., HABTEMARIAM, S.,; Rahimi–Madiseh, M., Lorigooini, Z. (2022). The effect of aqueous extract of black radish root on urine pH in stone-forming patients: A single blind clinical trial. Future Natural Products 8(2), 30-34. FULL TEXT or PDF

  20. Nekoei, S., Khamesipour, F., HABTEMARIAM, S., de Souza, W., Mohammadi Pour, P., Hosseini, S.R. (2022) The anti-Trypanosoma activities of medicinal plants: A systematic review of the literature. Veterinary Medicine and Science,  Published on 29 August 2022 FULL TEXT

  21. Nabavi, S.F., Sahebnasagh, A., Shahbazi, A., Nabavi, S.M., Rahmani, M., Azimi, S., Kashani, M.K., HABTEMARIAM, S.; Badiee, M., Hashemi, J., Saghafi, F., Amini, K., Azimi, M., Rezabakhsh, A. (2022). Putative therapeutic impact of inflammasome inhibitors against COVID-19 driven ARDS. Current Medicinal Chemistry, Published online on 6 September 2022. Abstract

  22. Amini, S., Rezabakhsh, A., Hashemi, J., Saghafi, F., Azizi, H., Sureda, A., HABTEMARIAM, S., Khayat, Kashani, H.R, Hesari, Z., Sahebnasagh, A. (2022) Pharmacotherapy consideration of thrombolytic medications in COVID-19-associated ARDS. J. Intensive Care 10(1), 38.  FULL TEXT

  23. Sureda, A., HABTEMARIAM, S., Nabavi, S.M. (2022). The Pharmacology of COVID-19. Chemico-Biological Interaction 362, 110005. Abstract

  24. Mbida, H., Tsala, D.E., Aboubakar, S., HABTEMAIAM, S., Edmond, J.J., Bakwo, E.F., Minkande, J.Z.  (2022). Antioxidant activity of aqueous extract of leaves and seeds of Datura metel (Solanaceae) in frog’s heart failure model. Evidence-Based Complementary and Alternative Medicine (eCAM). 2022, 5318117. Full Text

  25. Naveed, M., Makhdoom, S.I., Abbas, G., Safdari, M., Farhadi, A., HABTEMARIAM, S., Shabbir, M.A., Jabeen, K., Asif, M.F., Tehreem, S. (2022). The vulent hypothetical proteins: The potential drug target involved in bacterial pathogenesis. Mini. Rev. Med. Chem. Published online on 13 April 2022. Abstract

  26. Ala, A., HABTEMAIAM, S.,   Vahdati, S.S.  Rezabakhsh, A. (2022). Cervical and Preauricular Lymphadenopathies as Atypical Manifestations in The Setting of COVID-19: Case Report. Future Virology - Published online on 12 February 2022. FULL TEXT

  27. Pourdowlat, G., Saghafi, F., Mozafari A., Sahebnasagh, A., Abedini, A., Meybodi, M.N., Nezam Abadi, A.S., Mousavinasab, S.R., Kiani, A., Raji, H., Soltani, N., Baeis, M.G.,   Eidani, E., Yakhdani, A.S.,   Movaseghi, F., HABTEMAIAM, S., Meybodi, Z.A., Jelodar, M.G. (2022).  Efficacy and safety of colchicine treatment in patients with COVID-19: A prospective, multi-center, randomized clinical trial. Phytotherapy Research 36(2), 891-898. Abstract

  28. Kashani, H.R.K., Alizade, P., Salimi, S., HABTEMARIAM, S., Kashani, M.K., Tewari, D. (2022).  Epidemiologic profile and outcome of primary pediatric brain tumors in Iran: Retrospective study and literature review. Child's Nervous System 38(2), 353-360.  Abstract

  29. Sahebnasagh, A., Saghafi, F., Ghasemi, A., Akbari, J., Alipour, A., HABTEMARIAM, S., Safdari, M., Ghaleno, H.R., Salehifar, E. (2022).  Aloe vera for prevention of acute radiation proctitis in colorectal cancer: A preliminary randomized, placebo-controlled clinical trial. Journal of Gastrointestinal Cancer 53(2), 318-325.  Abstract

  30. Devi, K.V., Pourkarim, M.R., Thijssen, M., Sureda, A., Khayatkashani, M., Cismaru, C.A., Berindan-Neagoe, I., HABTEMAIAM, S.,   Razmjouei, S. (2022). A perspective on the applications of furin inhibitors for the treatment of SARS-CoV-2. Pharmacological Reports  Pharmacological Reports 74(2), 425-430. FULL TEXT or PDF

  31. Sahebnasagh, A., Avan, R., Monajati, M.,   Hashemi, J., HABTEMARIAM, S., Negintaji, S.,   Saghafi F. (2022). L-Carnitine: Searching for new therapeutic strategy for sepsis management. Current Medicinal Chemistry 29(18), 3300-3323. Abstract

  32. Bandiwadekar, A., Jose, J., Khayatkashani, M., HABTEMARIAM, S., Kashani, H.R.K., Nabavi, S.M. (2022). Emerging novel approaches for the enhanced delivery of natural products for the management of neurodegenerative diseases. Journal of Molecular Neuroscience  72(3), 653-676.  Abstract

  33. Aneva, I., HABTEMARIAM, S., Banach, M., Sil, P., Sarkar, K., Sahebnasagh, Kamal, M.A., Khayatkashani, Kashani, R.K. (2022). Can we use mTOR inhibitors for  COVID-19 therapy? Combinatorial Chemistry & High Throughput Screening 25(11), 1805-1808.  Abstract

  34. Sahebnasagh, A., Nabavi, S.M., Kashani, H.R.K., Abdollahian, S.; HABTEMARIAM, S.; Rezabakhsh, A. (2021). Anti-VEGF agents: As appealing targets in the setting of COVID-19 treatment in critically ill patients. International Immunopharmacology 101 (Part B), 108257.  Published online on 16 October 2021 Abstract

  35. Manayi, A., Nabavi, S.M., Khayatkashani, M., HABTEMARIAM, S., Reza H., Kashani K. (2021). Arglabin could target inflammasome-induced ARDS and cytokine storm associated with COVID-19. Molecular Biology Reports. FULL TEXT or PDF

  36. Sahebnasagh,  A.,   Hashemi,  J.,  Khoshi,  A.,   Saghafi,   F.,  Avan,   R., Faramarzi,  F.,  Azimi,   S., HABTEMARIAM, S.,    Sureda, A.,  Khayatkashani, M.,  Safdari, M.,  Ghaleno, H.R.,  Soltani,  H., Kashani,  H.R.K. (2021). Aromatic hydrocarbon receptors in mitochondrial biogenesis and function. Mitochondrion 61, 85-101. Abstract

  37. Satari, A., Ghasemi, S., HABTEMARIAM, S., Asgharian, S., Lorigooini, Z., (2021). Rutin: A flavonoid as an effective sensitizer for anticancer therapy; Insights into multifaceted mechanisms and applicability for combination therapy. Evidence-Based Complementary and Alternative Medicine 2021, 9913179. FULL TEXT  or PDF

  38. Yazarlu, O., Iranshahi, M., Kashani, H.R.K., Reshadat, S., HABTEMARIAM, S., Iranshahy, M., Hasanpour, M. (2021).  Perspective on the application of medicinal plants and natural products in wound healing: A mechanistic review. Pharmacological Research 174, 105841. Published online on 20 August 2021. Abstract

  39. Annunziata, A., Sureda, A., Orphan, I.E., Battino, M., Arnone, A., Jim´enez-García, M., Capo´,  X.,  Cabotj, J.,  Sanadgol, N.,   Giampieri, F ,   Tenore, G.C.,  Kashani H.R.K., Silva, A.S., HABTEMARIAM, S.,   Nabavi, S.F.,   Nabavi, S.M. (2021).  The neuroprotective effects of polyphenols, their role in innate immunity and the interplay with the microbiota. Neuroscience and Biobehavioral Reviews 128, 437-453. Abstract

  40. Süntar, I., Çetinkaya, S., Haydaroğlu, U.S., HABTEMARIAM, S. (2021). Bioproduction process of natural products and biopharmaceuticals: Biotechnological Aspects. Biotech Adv. Published Online on 8 May 2021 Abstract

  41. Minkande, J.Z.,   Aboubakar, S.,   Tsala, D.M., HABTEMARIAM, S.,   Nnanga, N. (2021). Cardiotonic activity of the aqueous extract of euphorbia poissonii on the isolated frog heart. J. Complement. Med. Res.   12(1), 107-112.  Abstract or PDF

  42. Mojtahedzadeh, M., Boojar, M.M.A.,  HABTEMARIAM, S., Nabavi, S.M., Najafi, A., Ghahremanian, A., Baktash, M., Aghaabdollahian, S., Bagheri, M. (2021). Systematic review: effectiveness of herbal oral care products on ventilator-associated pneumonia. Phytotherapy Research.   35(7), 3665-3672.   Abstract

  43. Delice, O., Vahdati, S.S., Arslan, S., Ala, A., Hosseinifar, H., Houshmand, F., HABTEMARIAM, S., Rezabakhsh, A.  (2021). A comparative study of the registry system effect on patients satisfaction rate in two emergency department settings. Bulletin of Emergency and Trauma 9(3), 138-144.  FULL TEXT or PDF

  44. Milani, G., Cavalluzzi, M.M., Solidoro, R., Salvagno, L., Quintieri, L., Di Somma, A., Rosato , A., Corbo, F., Franchini, C., Duilio, A., Caputo, L., HABTEMARIAM, S., Lentini, G. (2021).  Molecular simplification of natural products: Synthesis, antibacterial activity, and molecular docking studies of berberine open models. Biomedicines 9(5), 452. FULL TEXT  or PDF

  45. Firozabad, A.R., Meybodi, Z.A., Mousavinasab, S.R., Sahebnasagh, A., Jelodar, M.G., Karimzadeh, I., HABTEMARIAM, S., Saghafi, F. (2021). Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial. BMC Infectious Diseases  21(1) 297.  FULL TEXT or PDF

  46. Sharma, A.,   Tewari, D., Nabavi, S.F., Nabavi, S.M., HABTEMARIAM, S. Reactive oxygen species modulators in pulmonary medicine. (2021). Current Opinion in Pharmacology 57, 157-164.  Abstract

  47. Sadeghimanesh, A., Gholipour, S., Torki, A., Amini-khoei, H., Lorigooini, Z., HABTEMARIAM, S. (2021). Inhibitory effects of Nigella sativa seed oil on the testosterone-induced benign prostatic hyperplasia in rats. BioMedicine 11(1), 2 FULL TEXT or PDF

  48. Rasekhian, M., Roohvand, F., HABTEMARIAM, S., Marzbany, M., Kazemimanesh M. (2021).  The role of 3'UTR of RNA viruses on mRNA stability and translation enhancement.  Mini-Reviews in Medicinal Chemistry 21(16), 2389-2398.    Abstract

  49. Nabavi, S.F., HABTEMARIAM, S.,   Berindan-Neagoe, I.,   Cismaru, C.A.,  Schaafsma, D.,  Ghavami, S.,   Banach M.,    Nabavi, S.M. (2021). Rational for effective prophylaxis against COVID-19 through simultaneous blockade of both endosomal and non-endosomal SARS-CoV-2 entry into host cell. Clinical and Translational Science 14(2), 431-433.   Abstract

  50. Carocci, A.,   Budriesi. R., Micucci, M.,  Cavalluzzi, M.M., Milani, G.,   Catalano, A., De Palma, A.  Corbo, F.  Franchini, C., HABTEMARIAM, S., Giovanni, L. (2021). Synthesis and evaluation of voltage‐gated sodium channel blocking pyrroline derivatives endowed with both antiarrhythmic  and antioxidant activities. ChemMedChem 16(3), 578-588.  Abstract

  51. Soleymani, S., HABTEMARIAM, S.,  Rahimi, R., Nabavi, S.M. (2020). The what and who of dietary lignans in human health: Special focus on prooxidant and antioxidant effects. Trends in Food Science & Technology 106, 382-390. Abstract

  52. Harley, B.K., Dickson, R.A., Amponsah, I.K., Ben, I.O., Adonjo, D.W., Fleischer, T.C., HABTEMARIAM, S. (2020).  Flavanols and triterpenoids from Myrianthus arboreus ameliorate hyperglycaemia in streptozotocin-induced diabetic rats possibly via glucose uptake enhancement and α-amylase inhibition.  Biomedicine & Pharmacotherapy 132, 110847 Published online on 14 October 2020. FULL TEXT

  53. Elufioye,  T.O.,  HABTEMARIAM, S.,   Adejare  A.,  (2020). Drug development for the management of corona viruses: Insights from natural antiviral agents. Tropical Journal of  Natural Product Research   4(9), 490-511. FULL TEXT or PDF

  54. Elufioye,  T.O.,  HABTEMARIAM, S.,   Adejare  A.,  (2020). Chemistry and pharmacology of alkylamides from natural origin. Revista Brasileira de Farmacognosia (Brazilian Journal of Pharmacognosy)  30, 622-640. FULL TEXT or PDF

  55. Hushmandi, K., Bokaie, S., Hashemi, M., Rahmani, E., Moghadam, Raei, M., Hashemi, F., Bagheri, M., HABTEMARIAM, S., Nabavi, S.M. (2020). A review of medications used to control and improve the signs and symptoms of COVID-19 patients. European Journal of Pharmacology  887, 1735568.  FULL TEXT

  56. Nabavi, S.F. HABTEMARIAM, S., Sureda, A. Banach, M. Berindan-Neagoe, I. Cismaru, C.A., Bagheri, M. Bagheri  M.S., Nabavi, S.M. (2020). Glucose-6-phosphate dehydrogenase deficiency and SARS-CoV-2 mortality: Is there a link and what should we do? Clinical Biochemistry 86, 31-33.  FULL TEXT

  57. Sahebnasagh, A., Saghafi, F., Avan, R., Khoshi, A., Khataminia, M., Safdari , M., HABTEMARIAM, S., Ghaleno, H.R.,  Nabavi, S.M. (2020). The Prophylaxis and Treatment Potential of Supplements for COVID-19. European Journal of Pharmacology 887, 173530.  FULL TEXT

  58. Sahebnasagh, A., Saghafi, F., Safdari, M., Khataminia, Sadremomtaz, A.,  Talaei, Z., Ghaleno, H.R.,  Bagheri, M.S.,     HABTEMARIAM, S., Avan, R. (2020).  Neutrophil Elastase Inhibitor (Sivelestat), may be a Promising Therapeutic Option for Management of Acute Lung Injury/Acute Respiratory Distress Syndrome or Disseminated Intravascular Coagulation in COVID-19.  Journal of Clinical Pharmacy and Therapeutics  45, 1515-1519. FULL TEXT or PDF

  59. Sahebnasagh, A.,  Avan, R.,   Saghai, F.,  Mojtahedzadeh, M.,   Sadremomtaz, A.,  Arasteh, O., Tanzii, A., Faramarzi, F., Negarandeh, R.,  Safdari, M.,  Khataminia, M., Ghaleno, H.R., HABTEMARIAM, S., Khoshi, A.  (2020). Pharmacological treatments of COVID-19. Pharmacological Reports. 72(6), 1446-1478.  FULL TEXT or PDF

  60. Sarkar, K.,  Sil, P.C.,   Nabavi, S.F.,   Beridan-Neagoe, I.,   Cismaru, C.A.,   Nabavi, S.M.,  HABTEMARIAM, S*.  Possible Targets and Therapies of SARS-CoV-2 Infection. Mini Reviews in Medicinal Chemistry 20(18), 1900-1907. Abstract

  61. Dowran, R., Nabavi, S.F., HABTEMARIAM, S., Banach, M.,  Shahmohamadnejad, S., Cismaru, C.A., Berindan-Neagoe, I., Sahebnasagh, A., Nabavi S.M. (2020). Various  interferon (IFN)-inducible transmembrane (IFITM) proteins for COVID-19, is there a role for the combination of mycophenolic acid and interferon? Biochimie 177, 50-52.  FULL TEXT or PDF

  62. Sahebnasagh, A., Mojtahedzadeh, M.,   Najmeddin, F., Najafi, A.,    Safdari, M., Ghaleno, H.R., HABTEMARIAM, S.,   Berindan-Neagoe, I., Nabavi, S.F. (2020). A perspective on erythropoietin as a potential adjuvant therapy for acute lung injury/acute respiratory distress syndrome in patients with COVID-19. Archives of Medical Research 51(7),  631-635.    FULL TEXT

  63. HABTEMARIAM, S., Berindan-Neagoe, I., Cismaru, C.A., Schaafsma, D., NABAVI, S.F.,  Ghavami, S., Banach, M.,   Nabavi, S.M.  (2020) Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID-19: shoot the messenger!   Journal of Cellular and Molecular Medicine.  Available online 17 July 2020. FULL TEXT

  64. HABTEMARIAM, S., Nabavi, S.F., Banach, M., Berindan-Neagoe, I. Sarkar K.,  Sil, P.C. Nabavi, S.M.   (2020). Should we try SARS-CoV-2 helicase inhibitors for COVID-19 therapy? Archives of Medical Research 51(7), 733-735 Abstract  

  65. Shahmohamadnejad, S., Nabavi, S.F., HABTEMARIAM, S. Sarkar, K., Sil, P.C., Dowran, R., Nabavi, S.M. (2020). May we target double membrane vesicles and oxysterol-binding protein to combat SARS-CoV-2 infection? Cell Biology International 44(9), 1770-1772.   FULL TEXT or PDF

  66. HABTEMARIAM, S. (2020). Trametes versicolor (Synn. Coriolus versicolor) Polysaccharides in Cancer Therapy: Targets and Efficacy. Biomedicines 8(5), 135. FULL TEXT or PDF

  67. HABTEMARIAM, S., Nabavi S.F., Ghavami, S., Cismaru, C.A., Berindan, N., Nabavi S.M. (2020). Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2. Pharmacological Research  157, 104853. Available online 30 April 2020 Abstract

  68. HABTEMARIAM, S., NABAVI, S.F., Berindan-Neagoe, I., Cismaru, C.A., Izadi, M., Sureda, A.,  Nabavi, S.M. (2020). Should we try the anti-inflammatory natural product, celastrol, for COVID-19? Phytotherapy Research 34(6), 1189-1190.  Anstract

  69. HABTEMARIAM, S. (2020). The Quest to Enhance the Efficacy of Berberine for Type-2 Diabetes and Associated Diseases: Physicochemical Modification Approaches. Biomedicines 8(4), 90. FULL TEXT or PDF

  70. Lentini, G., Cavalluzzi, M.M., HABTEMARIAM, S. (2020). COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help. Molecules 25(8), 1834. FULL TEXT

  71. Nabavi, S.F., HABTEMARIAM, S., Clementi, E., Berindan-Neagoe, I., Cismaru, C.A., Rasekhian, M., Banach, M., Izadi, M., Bagheri, M., Bagheri, M.S., Nabavi, S.M. (2020). Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us to combat SARS-CoV-2. Archives of Medical Science, 16(3), 519–521.  FULL TEXT  DOI: https://doi.org/10.5114/aoms.2020.94504 Published on 14 April 2020.

  72. Caputo, L., Lentini, G., HABTEMARIAM, S. (2020). Repurposing therapeutic agents and herbal medicines to defeat viral nemesis. Drug Discovery Research Published online on 30 March 2020. DOI: https://doi.org/10.1002/ddr.21668

  73. Tsala, D.E.,   Mbida, H., Nnanga, N., Lemba,  E.T.N, HABTEMARIAM, S., Ze, J.M. (2020). Mecanism and inotropic actions of the water extracts of the leaves and seeds of Datura metel (solanaceae) on isolated frog's heart. American Journal of Physiology, Biochemistry and Pharmacology 10(2), 40-47.  PDF

  74. HABTEMARIAM, S. (2020). Recent advances in berberine inspired anticancer approaches: From drug combination to novel formulation technology and dererivatization. Molecules 25(6), 1426. FULL TEXT or PDF

  75. HABTEMARIAM, S. (2020). Berberine pharmacology and the gut microbiota: A hidden therapeutic link. Pharmacological Research I155, 104722  Abstract

  76. Shahbazi,  B., Feyzmand,  S.  Jafari, F.  Ghiasvand, N. Bahrami, G.  Fattahi,  A. HABTEMARIAM,  S. Nabavi,  S.M. Shokoohinia, Y. (2020). Antidiabetic potential of Prosopis farcta roots: In vitro pancreatic beta cell protection, enhancement of glucose consumption, and bioassay-guided fractionation. Evidence-Based Complementary and Alternative Medicine, 2020: Article ID 8048273. FULL TEXT

  77. Nabavi, S.M., Šamec, D., Tomczyk, M., Milella, L., Russo, D., HABTEMARIAM, S., Suntar, I., Rastrelli, L., Daglia, M., Xiao, J., Giampieri, F., Battino, M., Sobarzo-Sanchez, E., Nabavi, S.F., Yousefi, B., Jeandet, P., Xu, S., Shirooie, S. (2020). Flavonoid biosynthetic pathways in plants: Versatile targets for metabolic engineering. Biotechnology Advances 38, pii: S0734-9750(18)30181-2. Abstract

  78. HABTEMARIAM, S. (2019). The chemistry, pharmacology and therapeutic potential of the edible mushroom Dictyophora indusiata (Vent ex. Pers.) Fischer (Synn. Phallus indusiatus). Biomedicines 7(4), 98. PDF

  79. HABTEMARIAM, S. (2019). The Nrf2/HO-1 axis as targets for flavanones: Neuroprotection by pinocembrin, naringenin and eriodictyol.  Oxidative Medicine and Cellular Longevity     2019, Article ID 4724920, 15 pages. Full Text or PDF

  80. Jeandeta, P., Sobarzo-Sánchezb, E., Silvad, A., Clémenta, C., Nabavie, S.F., Battinof, M.,    Rasekhiani, M., Belwalj, T., HABTEMARIAM, S., Koffasl, M., Nabavie, S.M. (2019). Whole-cell biocatalytic, enzymatic and green chemistry methods for the production of resveratrol and its derivatives. Biotechnology Advances, 39, 107461.  Available Online

  81. Kim, D.H., Khan, H., Ullah, H., Hassan, S.T.S., Šmejkal, K., Efferth, T., Mahamoodally, M.F., Xu, S., HABTEMARIAM, S., Filosa, R., Lagoa, R., Rengasamy, K.R. (2019). MicroRNA targeting by quercetin in cancer treatment and chemoprotection. Pharmacological Research 147, 104349. Abstract

  82. HABTEMARIAM, S. (2019). Modulation of reactive oxygen species in health and disease. Antioxidants 8(11), 513. FULL TEXT

  83. Lentini, G., Milani, G., HABTEMARIAM, S. (2019). The therapeutic power of green. Schizophrenia Research, 210, 310.  Link

  84. HABTEMARIAM, S. (2019). Antioxidant and rutin content analysis of leaves of the common buckwheat (Fagopyrum esculentum Moench) grown in the United Kingdom: A case study. Antioxidants 8(6), 160. FULL TEXT

  85. HABTEMARIAM, S. (2019). Antioxidant and anti-inflammatory mechanisms of neuroprotection by ursolic acid: Addressing brain injury, cerebral ischemia, cognition deficit, anxiety, and depression. Oxidative Medicine and Cellular Longevity    2019: Article ID 8512048, 18 pages. FULL TEXT

  86. HABTEMARIAM, S. (2019). Natural products in Alzheimer’s disease therapy: Would old therapeutic approaches fix the broken promise of modern medicines? Molecules   24(8), 1519. FULL TEXT or PDF

  87. Lentini, G., Milani G., HABTEMARIAM, S. (2019). Comment on “In situ derivatization of (RS)-mexiletine and enantioseparation using micellar liquid chromatography: A green approach. ACS Sustainable Chemistry & Engineering 7, 6424-6425. Link

  88. Taiwo, O.E., HABTEMARIAM, S. (2019). Hepatoprotective effects of rosmarinic acid: Insight into its mechanisms of action. Biomedicine & Pharmacotherapy 112, 108600. FULL TEXT or PDF

  89. Varghese, G.K, Abraham, R., Chandran, N.N, HABTEMARIAM, S. (2019). Identification of lead molecules in Garcinia mangostana L. against pancreatic cholesterol esterase activity: An in silico approach. Interdisciplinary Science: Computational Life Sciences. 11(12), 170-179. Abstract

  90. Ezzat S.M., El Bishbishy, M.H., HABTEMARIAM, S., Salehi, B., Sharifi-Rad, M., Martins, N., Sharifi-Rad, J. (2018). Looking at marine-derived bioactive molecules as upcoming anti-diabetic agents: A special emphasis on PTP1B inhibitors. Molecules 23(12), 3334. FULL TEXT

  91. Jeandet P., Sobarzo-Sánchez E., Clément C., Nabavi S.F., HABTEMARIAM S., Nabavi S.M., Cordelier S. (2018). Engineering stilbene metabolic pathways in microbial cells. Biotechnology Advances 36(8), 2264-2283. Abstract

  92. Nasseri, R., Farzaei, F., Navabi, F., HABTEMARIAM, S., Farzaei M.H., Khodarahmi, R., Tewari, D. (2018). Anthocyanins in the management of metabolic syndrome: A pharmacological and biopharmaceutical review. Frontiers in Pharmacology 9: 1310. Abstract

  93. Patra, J.K., Das, G., Fraceto, L.F., Campos, E.V.R, Rodriguez‑Torres, M. del Pilar, Acosta‑Torres, L.S., Diaz‑Torres, L.A.,    Grillo, R., Swamy, M.K., Sharma, S., HABTEMARIAM, S., Shin H-S. (2018). Nano based drug delivery systems: recent developments and future prospects. Journal of Nanobiotechnology 16:71. (33 pages). Full Text or PDF 

  94. Shirooie, S., Nabavi, S.F., Dehpour, A.R., Belwal, T., HABTEMARIAM, S., Argüelles, S., Sureda, A., Daglia, M., Tomczyk, M., Sobarzo-Sanchez, E., Xu, S., Nabavi, S.M. (2018). Targeting mTORs by omega-3 fatty acids: A possible novel therapeutic strategy for neurodegeneration? Pharmacological Research 135, 37-48. Abstract

  95. HABTEMARIAM, S. (2018). The brain-derived neurotrophic factor in neuronal plasticity and neuroregeneration: new pharmacological concepts for old and new drugs. Neural regeneration research 13(6), 983-984.  FULL TEXT or PDF

  96. Caputo, L., Quintieri, L., Cavalluzzi, M.M. Lentini, G., HABTEMARIAM, S.* (2018). Antimicrobial and Antibiofilm Activities of Citrus Water-Extracts Obtained by Microwave-Assisted and Conventional Methods. Biomedicines 2018, 6(2), 70. FULL TEXT, or PDF

  97. HABTEMARIAM, S.*, Lentini, G. (2018). Plant-derived anticancer agents: Lessons from the pharmacology of geniposide and its aglycone, genipin. Biomedicines 2018, 6(2), 39. (28 pages). FULL TEXT or PDF

  98. Mbatchou, V.C.,   Dickson, R.A., Amponsah, I.K., Mensah, A.Y. HABTEMARIAM, S. (2018). Protection effect of the anthraquinones, cassiatorin and aurantio-obtusin from seeds of Senna tora against cowpea weevil attack. Asian Pacific Journal of Tropical Biomedicine   8(2), 98-105.   FULL TEXT or PDF

  99. HABTEMARIAM, S. (2018). Molecular pharmacology of rosmarinic and salvianolic acids: Potential seeds for Alzheimer’s and vascular dementia drugs. Int. J. Mol. Sci.  19(2), 458. FULL TEXT

  100. HABTEMARIAM, S. (2018). Iridoids and other monoterpenes in the Alzheimer’s brain: Recent development and future prospects. Molecules 23(1), 117. FULL TEXT

  101. HABTEMARIAM, S. (2018). Antidiabetic potential of monoterpenes: A case of small molecules punching above their weight. International Journal of Molecular Sciences 19(1), 4. FULL TEXT

  102. Marya, Khan, H., Nabavi, S.M. HABTEMARIAM, S.  (2018). Anti-diabetic potential of peptides: Future prospects as therapeutic agents. Life Sciences 193, 153-158. Abstract

  103. Nabavi, S.F., Khan, H., D'onofrio, G., Šamec, D., Shirooie, S.,  Dehpour, A.R., Castilla, S.A.., HABTEMARIAM, S.,   Sobarzo-Sanchez, E. (2018). Apigenin as Neuroprotective Agent: Of mice and men. Pharmacological Research. 128, 359-365. Abstract

  104. HABTEMARIAM, S., Belai, A. (2018).  Natural Therapies of the inflammatory bowel disease: The case of rutin and its aglycone, quercetin. Mini Review in Medicinal Chemistry 18(3), 234-243. Abstract

  105. HABTEMARIAM, S. (2017). Could we really Use Aloe vera food supplements to treat diabetes? Quality control issues. Evidence-Based Complementary and Alternative Medicine (eCAM) 2017: 4856412. FULL TEXT or PDF

  106. Mbatchou, V.C., Tchouassi, D.P.,  Dickson, R.A.,  Annan, K.,  Mensah, A.Y. Amponsah, I.K.,  Jacob, J.W.,  Cheseto, X.,  HABTEMARIAM, S., Torto, B. (2017). Mosquito larvicidal activity of Cassia tora seed extract and its key anthraquinones aurantio-obtusin and obtusin. Parasites & Vectors 10, 562.  FULL TEXT

  107. Braidy, N., Behzad, S., HABTEMARIAM, S., Ahmed, T., Daglia, M., Nabavi, S.M., Sobarzo-Sanchez, E., Nabavi, S.F. (2017). Neuroprotective effects of citrus fruit-derived flavonoids, nobiletin and tangeretin in Alzheimer's and Parkinson's disease. CNS Neurol Disord Drug Targets 16(4), 387-397. Abstract

  108. Belwal, T., Nabavi, S.F., Nabavi, S.M., HABTEMARIAM, S.* (2017).  Dietary anthocyanins and insulin resistance: When food becomes a medicine. Nutrients   9(10), 1111. FULL TEXT or PDF

  109. HABTEMARIAM, S. (2017). Methodology for rapid Isolation of moringin: Potential anticancer compound from the seeds of Moringa stenopetala. Pharmaceutica Analytica Acta 8(8), 558.  FULL TEXT

  110. Elufioye,T.O.,  Berida, T.I.,   HABTEMARIAM S.*  (2017). Plants-derived neuroprotective agents: Cutting the cycle of cell death through multiple mechanisms. Evidence-Based Complementary and Alternative Medicine 2017 2017:3574012. 27 pages. FULL TEXT or PDF

  111. HABTEMARIAM, S. (2017). Protective effects of caffeic acid and the Alzheimer's brain: An update. Mini Review in Medicinal Chemistry 17(8), 667-674. Abstract

  112. HABTEMARIAM, S. (2017). Could we really use Aloe vera food supplements to treat diabetes? International Journal of Diabetes and Clinical Research  4:070 FULL TEXT

  113. Degennaro, L., Zenzola, M., Laurino, A., Cavalluzzi1, M.M., Franchini, C., HABTEMARIAM, S., Matucci, R., Luisi, R., Lentini, G. (2017). 2-Arylazetidines as ligands for nicotinic acetylcholine receptors.  Chem. Heterocycl. Compd., 53(3), 329–334. Abstract

  114. HABTEMARIAM, S. (2017). Going back to the good old days: The merit of crude plant drug mixtures in the 21st century. International Journal of Complementary & Alternative Medicine 6(2), 2017:1-5. FULL TEXT

  115. Lentini, G., HABTEMARIAM, S. (2017). The trivial names of citrus limonoids. Food Chemistry 225, 288. Abstract

  116. Kumatia, E.K., Annan, K., Dickson, R.A.,  Mensah, A.Y.,  Amponsah, I.K., Appiah, A.A.,  Tung, N.H.,  Edoh, D.A., HABTEMARIAM, S.* (2017). Antiinflammatory and analgesic effects in rodent models of ethanol extract of Clausena anisata roots and their chemical constituents. Natural Product Communications 12(1), 67-72.

  117. HABTEMARIAM, S.*, Varghese, G.K. (2017). Antioxidant, anti-alpha-glucosidase and pancreatic beta-cell protective effects of methanolic extract of Ensete superbum Cheesm seeds. Asian Pacific Journal of Tropical Biomedicine 7(2), 121–125. Full Text  or PDF

  118. Nabavi, S.F., HABTEMARIAM, S., Daglia, M., Sureda, A., Sobarzo-Sánchez, E., Selamoglu, Z., Gulhan, M.F., Nabavi, S.M. (2017) Melatonin and respiratory diseases: a review. Current Topics in Medicinal Chemistry 17(4), 467-488. Abstract

  119. Gualdani, R., Cavalluzzi, M.M., Lentini, G., HABTEMARIAM, S. (2016). The chemistry and pharmacology of citrus limonoids. Molecules 21(11), 1530.  FULL TEXT or PDF

  120. HABTEMARIAM, S. (2016). Berberine and inflammatory bowel disease: A concise review. Pharmacological Research 113(Part A), 592-599. Abstract

  121. Roselli, M., Cavalluzzi, M.M., Bruno, C., Lovece, A., Carocci, A., Franchini, C., HABTEMARIAM, S., Lentini, G. (2016). Synthesis and evaluation of berberine derivatives and analogues as potential anti-acetylcholinesterase and antioxidant agents. Phytochemistry Letters 18, 150-156. Abstract

  122. Nabavi, S.F., Maggi, F., Daglia, M., HABTEMARIAM S., Rastrelli, L., Nabavi, S.M. (2016). Pharmacological effects of Capparis spinosa L.  Phytotherapy Research    30(11), 1733-1744. Abstract

  123. Roselli, M., Carocci, A., Budriesi, R., Micucci, M., Toma, M., Di Cesare Mannelli, L., Lovece, A., Catalano, A., Cavalluzzi, M.M., Bruno, C., De Palma, A., Contino, M., Perrone, M.G., Colabufo, N.A., Chiarini, A., Franchini, C., Ghelardini, C., HABTEMARIAM, S., Lentini, G. (2016). Synthesis, antiarrhythmic activity, and toxicological evaluation of mexiletine analogues. European Journal of Medicinal Chemistry 121, 300 – 307. Abstract

  124. HABTEAMRIAM, S. (2016). The Therapeutic Potential of Rosemary (Rosmarinus officinalis) Diterpenes for Alzheimer’s Disease. Evidence-Based Complementary and Alternative Medicine, Volume 2016 (2016), Article ID 2680409, 14 pages. FULL TEXT or PDF

  125. HABTEMARIAM, S. (2016). The African Moringa is to change the lives of millions in Ethiopia and far beyond. Asian Pacific Journal of Tropical Biomedicine 6(4), 355-356.  FULL TEXTor PDF

  126. HABTEMARIAM, S. (2016). Rutin as a natural therapy for Alzheimer’s disease: Insights into its mechanisms of action. Current Medicinal Chemistry 23(9), 860-873. Abstract

  127. Nabavi, S.F., HABTEMARIAM, S., Di Lorenzo, A., Sureda, A., Khanjani, S., Nabavi, S.M., Daglia, M. (2016). Post-stroke depression modulation and in vivo antioxidant activity of gallic acid and its synthetic derivatives in a murine model system. Nutrients 8(5), 248. PDF

  128. Tsala, D.E., Lannang, A.M., Dimo, T., HABTEMARIAM, S., Ekanga, J.A., Guemmogne, B.M., Sewald, N.  (2016). Antidiabetic and wound healing effects of smeathxanthone A. Recent Advances in Biology and Medicine 2, 5-10. Full Text or PDF

  129. Nabavi, S.F., Braidy, N., HABTEMARIAM, S., Sureda, A., Manayi, A., Nabavi, S.M. (2016). Neuroprotective effects of fisetin in Alzheimer’s and Parkinson’s Diseases: From chemistry to medicine. Current Topics in Medicinal Chemistry, 16(17), 1910-1915.  Abstract

  130. Manikandan, R., Thiagarajan, R., Goutham, G., Arumugam, M., Beulaja, M., Rastrelli, L., Skalicka-Woźniak, K, HABTEMARIAM, S., Orhan, I. E., Nabavi, S.F., Nabavi, S.M.  (2016). Zeaxanthin and ocular health, from bench to bedside. Fitoterapia 109, 58-66. Abstract

  131. Shah, M.R., HABTEMARIAM, S.,  Zarrelli, A., Muhammad, A.,  Collina, S., Khan, I. (2016). Protein Tyrosine Phosphatase 1B inhibitors isolated from Artemisia roxburghiana. Journal of Enzyme Inhibition and Medicinal Chemistry 31(4), 563-567. Abstract

  132. Manaye, A., Abdollahi, M., Thiagarajan, R., Nabavi, S.F., HABTEMARIAM, S., Daglia, M., Badiee, A., Nabavi, S.M. (2016).  Lutein and Cataract: from bench to beside. Critical Reviews in Biotechnology 36(5), 829-839.  Abstract

  133. Tsala, D.E., Joseph, M.N., Heroylnr, L.T., HABTEMARIAM, S. (2016). In vivo wound healing effect of water extract of Stereospermum kunthianum Cham. stem bark. Journal of Medicinal Herbs and Ethnomedicine 2016, 2, 1-6. PDF

  134. Lentini, G., HABTEMARIAM, S. (2015). Plotting intersections. Nature Methods 12(4), 281. Abstract

  135. HABTEMARIAM, S., Varghese, G.K. (2015). Extractability of Rutin in Herbal Tea Preparations of Moringa stenopetala Leaves. Beverages, 19(3, 169-182. FULL TEXT or PDF

  136. Nabavi, S.F., Braidy, N., Habtemariam, S., Orhan, I.E., Daglia, M., Manayi, A., Gortzi O., Nabavi, S.M. (2015). Neuroprotective effects of chrysin: From chemistry to medicine. Neurochemistry International 90, 224-231. Abstract

  137. Nabavi, S.F., Bilotto, S., Russo, G.L., Orhan, I.E, HABTEMARIAM, S., Daglia, M., Devi, K.P., Loizzo, M.R., Tundis, R., Nabavi, S.M. (2015).  Omega-3 polyunsaturated fatty acids and cancers: Lessons learnt from clinical trials. Cancer & Metastasis Reviews 34(3), 359-380. Abstract  

  138. Devi K.P., Rajavel T., HABTEMARIAM S., Nabavi S.F., Nabavi S.M. Molecular mechanisms underlying the anticancer effects of myricetin. Life Sciences 142, 19-25. Abstract 

  139. Roselli, M., Lovece, A., Bruno, C., Cavalluzzi, M.M., Laghezza, A., Mercurio, A., Lentini, G., Corbo, F., la Forgia, F., Fontana, S. HABTEMARIAM, S., Franchini, C. (2015).   Antioxidant Activity of Uva di Troia Canosina: Comparison of Two Extraction Methods. Clinical Immunology, Endocrine & Metabolic Drugs 2(1), 8-12.  Abstract

  140. Nabavi, S.F., HABTEMARIAM, S., Ahmed, T., Sureda, A., Daglia, M., Sobarzo-Sánchez, E., Nabavi, S.M. (2015).  Polyphenolic composition of Crataegus monogyna Jacq.: from chemistry to medical applications. Nutrients 7(9), 7708-7728. Abstract  

  141. Nabavi, S.M., HABTEMARIAM, S., Daglia, M., Loizzo, M.R., Tundis, R., Nabavi, S.F. (2015). Neuroprotective effects of ginkgolide B against ischemic stroke. Current Topics in Medicinal Chemistry 15(21), 2222-2232.   Abstract

  142. de Oliveira, M.R., Nabavi, S.F., HABTEMARIAM, S., Orhan, I.E., Daglia, M., Nabavi, S.M. (2015). The Effects of Baicalein and Baicalin on Mitochondrial Function and Dynamics: A Review. Pharmacological Research 100, 296-308.  Abstract

  143. Spagnuolo, C., Russo, G.U., Orhan, I.E., HABTEMARIAM, S., Daglia, M., Sureda, A., Nabavi, S.F., Devi, K.P., Loizzo, R.M., Tundis R., Nabavi, S.M. (2015). Genistein and cancer: current status, challenges, and future direction. Advances in Nutrition 6(4), 408-419. Abstract

  144. Civenni, G., Iodice, M.G., Nabavi, S.F., HABTEMARIAM, S., Nabavi, S.M., Catapano, C.V., Dagli M.G. (2015). Gallic acid and methyl-3-O-methyl gallate: a comparative study on their effects on prostate cancer stem cells. RSC Advances 5, 63800–63806. Abstract

  145. Armah, F.A., Annan, K, Mensah, A.Y.,   Amponsah, I.K., Tocher, D.A., HABTEMARIAM, S.* (2015). Erythroivorensin A: a novel antiifnlammatory diterpene from the root-bark of Erythrophleum ivorense (A Chev.). Fitoterapia 105, 37-42. Abstract

  146. HABTEMARIAM, S.* and Lentini, G. (2015). The therapeutic potential of rutin for diabetes: An update. Mini Review in Medicinal Chemistry 15(7), 524-528. Abstract

  147. Álvarez, Á.L., HABTEMARIAM, S., Dalton, K.P., Nicieza, I., Parra, F. (2015. A spiroketal-enol ether derivative from Tanacetum vulgare selectively inhibits HSV-1 and HSV-2 glycoprotein accumulation in Vero cells. Antiviral Research 119, 8-18. Abstract

  148. Jackson N., Annan, K., Mensah, A.Y., Ekuadzi, E., Mensah, M.L.K., HABTEMARIAM, S.* (2015). A novel triterpene from the roots of Paullinia pinnata:  6a-(3’-methoxy-4’-hydroxybenzoyl)-lup-20(29)-ene-3-one. Natural Product Communications 10(4), 563-564.  Abstract PDF-PROOF

  149. HABTEMARIAM, S. (2015). Investigation into the antioxidant and antidiabetic potential of Moringa stenopetala: Identification of the active principles. Natural Product Communications 10(3), 475-478. Link

  150. Nabavi, S.M., HABTEMARIAM, S., Daglia, M., Nabavi, S.F. (2015). Apigenin and breast cancers: From chemistry to medicine. Anti-Cancer Agents in Medicinal Chemistry 15(6), 728-35.  Abstract  

  151. Álvarez, Á.L., Parra, F., HABTEMARIAM, S. (2015). Inhibitory effects of lupene-derived pentacyclic triterpenoids from Bursera simaruba on HSV-1 and HSV-2 in vitro replication. Natural Product Research 29(24), 2322–2327. Abstract

  152. Nabavi, S.F., Sureda, A., HABTEMARIAM, S., Nabavi, S.M. (2015). Ginkgolide Rd and ischemic stroke, a short review of literatures. Journal of Ginseng Research 39(4), 299-303.  Abstract  

  153. HABTEMARIAM, S., Lentini, G. (2015). Did Ebola Survivors Use Plant Medicines, and if so, Which Ones? Phytotherapy Research 29(4), 632. Abstract

  154. Lentini, G., HABTEMARIAM, S. (2015). "Ebola therapy: Developing new drugs or repurposing old ones? International Journal of Cardiology 179, 325. Abstract [March 3rd 2015 - Listed as one of the most downloaded paper]

  155. HABTEMARIAM, S., Varghese, G.K. (2015). A Novel Diterpene Skeleton: Identification of a highly aromatic, cytotoxic and antioxidant 5-methyl-10-demethyl-abietane-type diterpene from Premna serratifolia. Phytotherapy Research 29(1), 80-85.  Abstract

  156. Nabavi, S.F., HABTEMARIAM, S., Daglia, M., Shafighi, M., Barber, A.J., Nabavi, S.M. (2015). Anthocyanins as a potential therapy for diabetic retinopathy. Current Medicinal Chemistry 22(1), 51-58.  Abstract

  157. Mireku, E.A., Mensah, A.Y., Mensah, M.L.K., Tocher, D.A., HABTEMARIAM, S.*. (2014). Anti-inflammatory properties of the stem-bark of Anopyxis kalineana and its major constituent, methyl angolensate. Phytotherapy Research 28(12), 1855–1860. Abstract

  158. HABTEMARIAM, S. and Varghese, G.K. (2014). The antidiabetic therapeutic potential of dietary polyphenols. Current Pharmaceutical Biotechnology 15(4), 391-400. Abstract 

  159. Tsala, D.E., HABTEMARIAM S., Simplice, F.H.,   Thiery B.N.M., Abraham, J.A., Theophile, D. (2014).  Topically applied Tetrapleura tetraptera stem bark extract promotes healing of excision and incision wounds in rats. Journal of Intercultural Ethnopharmacology 3(2), 63–67. Abstract

  160. Varghese, G.K., Diana K.J., HABTEMARIAM, S.  (2014). In vitro studies on indigenous medicine for urolithiasis: Efficacy of aqueous extract of Aerva lanata (Linn.) Juss. Ex Schult on growth inhibition of calcium hydrogen phosphate dihydrate. THE PHARMA INNOVATION – JOURNAL 3(1), 92-100.  FULL TEXT

  161. Curti, V., Capelli, E., Nabavi, S.F., HABTEMARIAM, S., Nabavi, S.M., Daglia, M. (2014). Modulation of human miR-17-3p expression by methyl 3-O-methyl gallate as explanation of its in vivo protective activities. Molecular Nutrition & Food Research 58(9), 1776-84. Abstract

  162. Lentini, G., HABTEMARIAM, S. (2014). Microchip capillary electrophoresis–electrospray ionization mass spectrometry analysis of paracetamol metabolites in human urine: An intriguing case. Journal of Chromatography A. 1327, 160. Abstract

  163. Nabavi, F.S., Daglia, M., HABTEMARIAM, S.,  Nabavi, S.M.  (2014). Curcumin and liver health, from chemistry to medicine. Comprehensive Reviews in Food Science and Food Safety 12(1), 62-77. Abstract

  164. HABTEMARIAM, S. (2013). The hidden treasure in Europe’s garden plants: Case examples; Berberis darwinni and Bergenia cordifolia. Medicinal & Aromatic Plants. 2:4. FULL TEXT

  165. Dawe, A., Pierre, S., Tsala, D.E., HABTEMARIAM, S. (2013). Phytochemical Constituents of Combretum Loefl. (Combretaceae). Pharmaceutical Crops 4, 38–59. FULL TEXT

  166. Nabavi, S.F., Sureda, A., Nabavi, S.M., HABTEMARIAM, S. (2013). In vivo protective effects of gallic acid isolated from Peltiphyllum peltatum against sodium fluoride-induced oxidative stress in erythrocytes.  Archives of Industrial Hygiene and Toxicology 64(4), 563-569. Abstract

  167. Tsala, D.E., Amadou, D., HABTEMARIAM, S. (2013). Natural wound healing and bioactive natural products. Phytopharmacology 4(3), 532-560. FULL TEXT

  168. Nabavi, S.M., HABTEMARIAM, S., Nabavi, S.F., Sureda, A., Moghaddam, A.H., Latifi, A.M. (2013). Prophylactic effect of methyl-3-O-methyl gallate against sodium fluoride-induced oxidative stress in rat’s erythrocytes in vivo. Journal of Pharmacy and Pharmacology 65(6), 868-873. Abstract

  169. Ahmed, S., Hasan, M.M., Ahmed, S.W., Mahmood, Z.A., Azhar, I., Habtemariam, S. (2013). Anti-emetic effects of bioactive natural products.  Phytopharmacology 4(2), 390-433.  FULL TEXT  

  170. Khan, I., Samad, A., Khan, A.Z., HABTEMARIAM, S., Badshah, A., Abdullah, S.M., Ullah N., Khan, A., Zia-Ul-Haq, M. (2013).  Molecular interactions of 4-acetoxy-plakinamine B with peripheral anionic and catalytic subsites of the aromatic gorge of acetylcholinesterase: Computational and structural insights. Pharmaceutical Biology 51(6), 722-727. Abstract

  171. Nabavi, S.F., Nabavi, S.M., HABTEMARIAM, S., Sureda, A., Moghaddam, A.H., Latifi, A.M. (2013). Neuroprotective effects of methyl-3-O-methyl gallate against sodium fluoride-induced oxidative stress in brain of rats. Cellular and Molecular Neurobiology 33(2), 261–267. Abstract

  172. HABTEMARIAM, S.*, Sureda, A., Moghaddam, A.H., Nabavi, S.F., Nabavi, S.M., Abolhasani, F. (2013). Protective role of gallic acid isolated from Peltiphyllum peltatum against sodium fluoride-induced oxidative stress in rat’s heart. Letters in Drug Design and Discovery 10, 277–282. Abstract

  173. Bose, L.V., Varghese, G.K., HABTEMARIASM, S*. (2013). Identification of acteoside as the active antioxidant principle of Premna serratifolia root wood tissues. Phytopharmacology. 4(2), 228–236.  FULL TEXT

  174. Nabavi, S.F., Nabavi, S.M., HABTEMARIAM, S., Sureda, A., Jafari, M., Abolhasani, F., Moghaddam, A.H. (2013). Hepatoprotective effect of gallic acid isolated from Peltiphyllum  peltatum against sodium fluoride-induced oxidative stress. Industrial Crops and Products 44, 50–55. Abstract

  175. Varghese, G.K., Bose, L.V., HABTEMARIASM, S*. (2013). Antidiabetic components of Cassia alata leaves: Identification through -glucosidase inhibition studies. Pharmaceutical Biology 51(3), 345-349. Abstract

  176. HABTEMARIAM S. (2013). Targeting the production of monocytes/macrophages-derived cytokines by anti-inflammatory herbal drugs. Phytopharmacology 4(1), 131–148. FULL TEXT

  177. Gupta, G., Kazmi, I., Afzal, M., Singh, R., Anwar, F., HABTEMARIAM, S. (2013). Antidepressant-like activity of Embelin isolated from Embelia ribes. Phytopharmacology 4(1), 87–95.  FULL TEXT

  178. HABTEMARIAM, S. (2013). Antihyperlipidemic components of Cassia auriculata aerial parts: Identification through in vitro studies. Phytotherapy Research 27(1), 152–155.  Abstract

  179. Nabavi, S.M., HABTEMARIAM, S., Nabavi, S.F., Sureda, A., Jafari, M., Abolhasani, F., Moghaddam, A.H. (2013).  Protective effect of gallic acid against sodium fluoride-induced oxidative stress in rat’s kidney. Molecular and Cellular Biochemistry 372(1-2), 233–239.  Abstract

  180. Nabavi, S.F., Nabavi, S.M., HABTEMARIAM, S*., Abolhasani,  F., Daglia,  M., Moghaddam, A.H. (2012). Protective effect of methyl-3-O-methyl gallate against sodium fluoride-induced oxidative stress in rat’s cardiac tissues. Fluoride 45(3 Pt 2), 290–296.  FULL TEXT

  181. HABTEMARIAM S. (2012). The anti-obesity potential of sigmoidin A. Pharmaceutical Biology 50(12), 1519-1522. Abstract

  182. Nabavi S.F, Nabavi S.M., Latifi A.M., Mirzaei M., HABTEMARIAM, S., Moghaddam, A.H. (2012). Mitigating role of quercetin against sodium fluoride induced oxidative stress in rat’s brain. Pharmaceutical Biology 50(11), 1380–1383. Abstract

  183. Nabavi S.M., Nabavi, S.F., HABTEMARIAM, S., Moghaddam, A.H., Latifi, A.M. (2012). Ameliorative effects of quercetin on sodium fluoride-induced oxidative stress in rat's kidney. Renal Failure   34(7), 901–906. Abstract

  184. Nabavi, S.F., HABTEMARIAM, S., Jafari, M, Sureda, A., Nabavi S.M. (2012). Protective role of gallic acid on sodium fluoride induced oxidative stress in rat brain. Bulletin of Environmental Contamination and Toxicology 89(1), 73–77.  Abstract

  185. HABTEMARIAM, S. (2012). Multifunctional small molecular weight compounds from Peltiphyllum peltatum: from antioxidant to neuroprotection and antidiabetic effects. Planta Medica 11(78), 1073. Abstract

  186. HABTEMARIAM, S. (2012). Identification of the antidiabetic and antihyperlipidemic principles of Cassia auriculata. Planta Medica 11(78), 1084.  Abstract

  187. HABTEMARIAM, S*., Cowley R.A. (2012). Antioxidant and anti-α-glucosidase compounds from the rhizome of Peltiphyllum peltatum (Torr.) Engl.  Phytotherapy Research 26(11), 1656–1660.  Abstract

  188. Lentini G., Bruno C., Roselli M., HABTEMAIAM, S., Jirillo E., Franchini C (2012). Activity of natural hydroxytyrosol versus a synthestic sample and its chiral analogues: hypothesis of mechanism of action.  Emirates Journal of  Food and Agriculture, 24, 30. Abstract

  189. Roselli, M., Lentini, G. and HABTEMARIAM, S*. (2012). Phytochemical, antioxidant and anti-alpha-glucosidase activity evaluations of Bergenia cordifolia. Phytotherapy Research 26(6), 908–914. Abstract

  190. Roselli, M., Lovece, A., Bruno, C., Lentini, G., Corbo, F., la Forgia F., Fontana, S., HABTEMARIAM, S., Franchini, C. (2012). Le Proprieta antiossidanti dell’uva di Troia Canosina ad acino piccolo: confronto tra differenti metodi estrattivi. Tutto Sanita 134, 32–35. Full Text

  191. HABTEMARIAM, S. (2011). Methyl-3-O-methyl gallate and gallic acid from the leaves of Peltiphyllum peltatum: isolation and comparative antioxidant, prooxidant, and cytotoxic effects in neuronal cells. Journal of Medicinal Food 14(11), 1412–1418. Abstract

  192. HABTEMARIAM, S. (2011). Targeting intestinal digestive enzymes by natural products: synergistic effects of flavonoids. Planta Medica 177(12), 1404. Abstract

  193. HABTEMARIAM, S. (2011). The therapeutic potential of Berberis darwinii stem-bark: quantification of berberine and in vitro evidence for Alzheimer’s disease therapy. Natural Product Communications 6(8), 1089–1090. Abstract, PDF-UNCORRECTED-PROOF

  194. HABTEMARIAM, S. (2011). a-Glucosidase inhibitory activity of kaempferol-3-O-rutinoside. Natural Product Communications 6(2), 201–203. Abstract

  195. Álvarez, Á.L., HABTEMARIAM., S., Juan-Badaturuge, M., Jackson, C., Parra, F. (2011).  In vitro anti HSV-1 and HSV-2 activity of Tanacetum vulgare extracts and isolated compounds: An approach to their mechanisms of action.  Phytotherapy Research. 25(2), 296–301. Abstract

  196. Juan-Badaturuge, M., HABTEMARIAM, S*., Thomas, M.J.K. (2011). Antioxidant compounds from a South Asian beverage and medicinal plant, Cassia auriculata. Food Chemistry 125(1), 221–225.  Abstract

  197. HABTEMARIAM, S. (2010). Knipholone anthrone from Kniphofia foliosa induces a rapid onset of necrotic cell death in cancer cells. Fitoterapia. 81(8), 1013–1019. Abstract

  198. Deshmukh, S.R., HABTEMARIAM, S., Wadegaonkar, P.A. (2010). Antioxidant and antiproliferative activity of root suspension culture of Morinda citrifolia L. Research Journal of Pharmacy & Technology 3(4), 1189–1193. Abstract

  199. Motlhanka, D., Houghton, P., Miljkovic-Brake A., HABTEMARIAM, S. (2010). A novel pentacyclic triterpene glycoside from a resin of Commiphora glandulosa from Botswana. African Journal of Pharmacy and Pharmacology 4(8), 549–554. Full Text

  200. HABTEMARIAM, S. (2010). Applying new science for old medicines: targeting leukocyte-endothelial adhesions by antiiflammatory herbal drugs. Natural Product Communications 5(8), 1329-1336.  - Abstract, PDF-UNCORRECTED-PROOF

  201. HABTEMARIAM, S.*, Dagne, E. (2010). Comparative antioxidant, prooxidant and cytotoxic activity of sigmoidin A and eriodictyol. Planta Med. 76(6), 589–594. Abstract

  202. Sánchez-Medina, A., Peña-Rodríguezb, L.M., May-Pat, F., Karagianisd, G., Waterman, P.G., Mallet, A.I., HABTEMARIAM S*. (2010). Identification of Sakurasosaponin as a Cytotoxic Principle from Jacquinia flammea. Natural Product Communications 5(3), 365–368.   Abstract, PDF-UNCORRECTED-PROOF

  203. Juan-Badaturugea, M., HABTEMARIAM, S.*, Jackson, C. and Thomas M.J.K. (2009). Antioxidant principles of Tanacetum vulgare L. aerial part.  Natural Product Communications 4(11), 1561–1564. Abstract,  PDF-UNCORRECTED-PROOF

  204. HABTEMARIAM, S., Dagne, E. (2009). Prooxidant action of knipholone anthrone: Copper dependent reactive oxygen species generation and DNA damage. Food and Chemical Toxicology, 47(7), 1490–1494. Abstract

  205. Sánchez-Medina, A., Stevenson, P.C., HABTEMARIAM, S., Peña-Rodríguez, L.M., Corcoran, O., Mallet, A.I.,   Veitch N.C. (2009). Triterpenoid saponins from a cytotoxic root extract of Sideroxylon foetidissimum subsp. gaumeri. Phytochemistry 70(6), 765–772. Abstract

  206. Hevesi, B.T., Houghton P.J., HABTEMARIAM, S.,   Kéry Á. (2009). Antioxidant and antiinflammatory effect of Epilobium parviflorum Schreb. Phytother. Res. 23(5), 719–724. Abstract

  207. HABTEMARIAM, S., Dagne, E. (2009). Differential cytotoxic and prooxidnant activity of knipholone and knipholone anthrone. Planta Medica    75(9), 885–885. Abstract

  208. HABTEMARIAM, S. (2008). Activity-guided Isolation and Identification of Free Radical-scavenging Components from Ethanolic Extract of Boneset (Leaves of Eupatorium perfoliatum). Natural Product Communications 3(8), 1317–1320. Abstract

  209. HABTEMARIAM, S. (2008). Activity-guided Isolation and Identification of Antioxidant Components from Ethanolic Extract of Peltiphyllum peltatum (Torr.) Engl. Natural Product Communications 3(8), 1321–1324. Abstract

  210.   Motlhanka, D.M.T., HABTEMARIAM, S.,   Houghton, P (2008).  Free radical scavenging activity of crude extracts and 4’-O-Methyl-(-) epigallocatechin isolated from roots of Cassine transvaalensis from Botswana. African Journal of Biomedical Research 11(1), 55–63. FULL TEXT

  211.  Motlhanka, D.M.T., Houghton, P, HABTEMARIAM, S. (2008) Antimicrobial activity of Clerodendrum uncinatum from Botswana. Bots. J. Agric.  App. Sci. 4(1), 70–75.

  212. HABTEMARIAM, S. (2007). Antioxidant activity of Knipholone anthrone. Food Chemistry 102(4), 1042–1047. Abstract

  213. HABTEMARIAM, S., Jackson, C. (2007). Antioxidant and cytoprotective activity of leaves of Peltiphyllum peltatum (Torr.) Engl. Food Chemistry 105(2), 498–503. Abstract

  214. Motlhanka, D.M.T., HABTEMARIAM, S.  (2007). Prostaglandin E-2 (PGE-2) inhibition by crude extracts of medicinal plants of Botswana.  Nigerian Journal of Natural Products and Medicine 11, 32–33. Abstract

  215. Hevesi, T.B., Houghton P.J.,  HABTEMARIAM S.,  Milligan S., Kalita C.J., Purohit A., Á Kéry (2007). Epilobium parviflorum Schreb. – in vitro study of biological action. Planta Medica   73(9), 45.  Abstract

  216. Motlhanka, D.M.T., Miljkovic-Brake, A., Houghton, P.J., HABTEMARIAM, S., Hylands, P.J. (2006). Antioxidant activity of water and ethanol extracts from Roots of Cassine transvaalensis Burtt-Davy from Botswana.  Planta Medica 72(11), 1001. Abstract

  217. Motlhanka, D.M.T., Miljkovic-Brake, A., Houghton, P.J., HABTEMARIAM., S., Hylands, P.J.  (2005). Antibacterial and Cytotoxic principles of Commiphora glandulosa stem bark resin. J. Pharmacy Pharmacol.   57(9) S-7.

  218. HABTEMARIAM, S. (2003). In vitro antileishmanial effects of antibacterial diterpenes from two Ethiopian Premna species: P. schimperi and P. oligotricha. BMC Pharmacology 2003, 3:6.  FULL TEXT

  219. HABTEMARIAM, S. (2003). Cytotoxic and cytostatic activity of erlangerins from Commiphora erlangeriana. Toxicon, 41(6), 723–727. Abstrat

  220. HABTEMARIAM, S. (2002). Hamamelitannin from Hamamelis virginiana inhibits the tumour necrosis factor-a (TNF)-induced endothelial cell death in vitro. Toxicon 40(1), 83–88. Abstract

  221. HABTEMARIAM, S. (2001). Antiinflammatory activity of the antirheumatic herbal drug, gravel root (Eupatorium purpureum): further biological activities and constituents. Phytotherapy Res. 15(8), 697–690. Abstract

  222. HABTEMARIAM, S., Skelton, B.W., Waterman, P.G., White, A.  (2000). 17-Epi-acnistin-A, a further withanolide from the leaves of Discopodium penninervium.  J. Nat. Prod. 63(4), 512–513. Abstract

  223. HABTEMARIAM, S. (2000). Natural inhibitors tumour necrosis factor-a production, secretion and function. Review article. Planta Med. 66(4), 303–313. Abstract

  224. HABTEMARIAM, S., MacPherson A.M. (2000). Cytotoxicity and antibacterial activity of ethanolic extract from leaves of a herbal drug, Boneset (Eupatorium perfoliatum). Phytotherapy Res. 14(7), 575–577. Abstract

  225. HABTEMARIAM, S. (1998).  Cistifolin, an integrin-dependent cell adhesion blocker from the anti-rheumatic herbal drug, gravel root (rhizome of Eupatorium purpureum). Planta Med. 64(8), 683–685. Abstract

  226. HABTEMARIAM, S. (1998). Extract of gravel root (rhizome of Eupatorium purpureum) inhibits integrins-dependent U937 cell adhesion. Phytotherapy Res. 12(6), 422–426.  Abstract

  227. HABTEMARIAM, S. (1998). Andrographolide inhibits the tumour necrosis factor-alpha-induced upregulation of ICAM-1 expression and endothelial-monocyte adhesion. Phytotherapy Res. 12(1), 37–40. Abstract

  228. Habtemariam, S. (1998). Extract of corn silk (stigma of Zea mays) inhibits the TNF and Bacterial Lipopolysacharide-induced cell adhesion and ICAM-1 expression. Planta Med. 64(4), 314–318. Abstract

  229. HABTEMARIAM, S. and Gray, A.I. (1998). Withanolides from the roots of Discopodium penninervium. Planta Med. 64(3), 275–276. Abstract

  230. HABTEMARIAM, S. (1997). Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells. J. Nat Prod. 60(8), 775–778. Abstract

  231. Habtemariam, S. (1997). Modulation of tumour necrosis factor-alpha-induced cytotoxicity by polyphenols Phytother. Res. 11(4), 277–280. Abstract

  232. Habtemariam S. (1997).  Cytotoxicity and immunosuppressive activity of withanolides from Discopodium penninervium. Planta Med., 63(1), 15–17. Abstract

  233. Habtemariam S. (1996). Cytotoxicity of extracts from the mushroom Paxillus involutus. Toxicon 34(6), 711–713. Abstract

  234. Harvey, A.L., Jerusalinsky, D., Kornisiuk, L., HABTEMARIAM, S. (1996). MTx1 and 2 from green mamba snake venom allosterically activate M1 and block other muscarinic receptor subtypes. Toxicon 34(3), 325.  Abstract

  235. Habtemariam, S., P.G. Waterman (1996). Fareanine and Fareanol from the leaves of Medicosma fareana. Phytochemistry 43(1), 291–294. Abstract

  236. Habtemariam, S. (1995). Cytotoxicity of diterpenes from Premna schimperi and Premna oligotricha. Planta Med. 61(4), 368–369. Abstract

  237. Habtemariam, S., Gray, A.I., Waterman, P.G. (1995).  Lignans from the leaves of Premna recinosa. Biochem. Ecol. Syst. 23(1), 109.

  238. Habtemariam, S. (1995). Catechols and quercetin reduce MTT through iron ions: a possible artefact in cell viability assay. Phytotherapy Res. 9(8), 603–605. Abstract

  239. Fetene, M., Habtemariam, S. (1995). Investigation on allelopathic properties of coffee (Coffea arabica L.) leaves, pulp and tree-canopy soil. SINET: Ethiop. J. Sci. 18, 51–65.

  240. Jerusalinsky, D., Harvey, A.L., HABTEMARIAM, S., Cerveñansky, C., Kornisiuk, E.  (1995). MTx1, a small protein from green mamba venom activates M1 and blocks M3 subtypes of muscarinic acetylcholine receptors. J.  Neurochem.    65, S152–S152.

  241. Habtemariam, S., Gray, A.I., Waterman, P.G. (1994).  Diterpenes from the leaves of Leonotis ocymifolia var raineriana. J. Nat. Prod. 57(11), 1570–1574.  Abstract

  242. Verma, A.K., Lee, C.Y., Habtemariam, S., Harvey, A.L., Jindal, D.P. (1994). Synthesis and biological activity of 17-azasteroidal neuromuscular blocking agents. Eur. J. Med. Chem.  29(5), 331–338.

  243. Habtemariam, S., Gray, A.I., Waterman, P.G. (1993). 16-oxygenated withanolides from the leaves of Discopodium penninervium. Phytochemistry 34(3), 807–811.

  244. Habtemariam, S., Harvey, A.L., Waterman, P.G. (1993). The muscle relaxant properties of Portulaca oleracea are associated with high concentrations of potassium ions. J. Ethnopharmacol. 40(3), 195–200. Abstract

  245. Habtemariam, S., Gray, A.I., Waterman, P.G. (1993). A new antibacterial sesquiterpene from Premna oligotricha J. Nat. Prod. 56(1), 140–143. Abstract

  246. Habtemariam, S., Gray, A.I., Waterman, P.G. (1992). Antibacterial diterpenes from the aerial parts of Premna oligotricha. Planta Med.  58(1), 109–110.

  247. Habtemariam, S., Gray, A.I., Lavaud, C., Massiot, G., Skelton, B.W., Waterman, P.G., White, A.H. (1991).  ent-12-Oxolabda-8,13(16)-dien-15-oic acid and ent-8b,12a-epidioxy-12b-hydroxylabda-9(11),13-dien-15-oic acid g-lactone: Two new diterpenes from the aerial parts of Premna oligotricha. J. Chem. Soc. Perkin Trans. I, 893–896. Abstract

  248. Habtemariam, S., Gray, A.I., Waterman, P.G. (1992). Flavonoids from three Ethiopian species of Premna. Z. Naturforsch., 47b(1), 144–147

  249. Habtemariam, S., Gray, A.I., Halbert, G.W. and Waterman, P.G. (1990). A novel antibacterial diterpene from Premna schimperi.  Planta Med. 56(2), 187-189. Abstract  

 

E: Representative International Conference Presentations

 

  1. HABTEMARIAM, S. (2019). Workshop on Health promoting and Disease preventing properties of African food plants and insects from East Africa. Organised by International Science Council. 07-08 October, 2019, Nairobi, Kenya. 

  2. HABTEMARIAM, S. (2018). The search for novel antidiabetic compounds of natural origin: Where are we now? Pharmaceut. Reg. Affairs 2018, 7:1(Suppl). Keynote speech at the 15th Annual European Pharma Congress 2018. Abstract/PDF

  3. HABTEMARIAM, S. (2017). New antiinflammatory compounds from old medicines: The science and art of pharmacognosy research in 21st century. Pharmaceut. Reg. Affairs 2017, 6:1(Suppl). Keynote speech at the 9th Annual European Pharma Congress 2017. Abstract/PDF

  4. HABTEMARIAM, S. (2015). Reviving old drugs for treating complex diseases: Going back to plant medicines? J Pharma Care Sys 2(4), 30. Keynote speech at the European Pharma Congress 2015. Abstract, PDF

  5. Tsala, D., Toussoumna, L., HABTEMARIAM, S. (2015). In Vivo Wound Healing Effect of Water Extract of Stereospernun kunthianum Stem-Bark.  World Academy of Science, Engineering and Technology, Volume: 3 (12).

  6. HABTEMARIAM, S. (2013). International conference on “The Molecular Secrets of Plant Medicines”. Jointly organised by the CMS College and Mahatma Ghandi University, Kerala, India. October 17-18, 2013. Two keynote lectures delivered – (i) The Molecular Secrets of Plant Medicines–Bioassay-Guided Isolation and Identification of Pharmacologically Active Compounds. (ii) The Molecular Secrets of Plant Medicines–Hot Multifunctional Therapeutic Targets of Interest. Media coverage - http://www.herbalanalysis.co.uk/MSPM2013-News.html

  7. Franchini, C., Lentini G., Bruno, C., Roselli, M., HABTEMARIAM, S., Birillo, E. (2012). Activity of natural hydroxytyrosol versus a synthetic sample and its chiral analogues: hypothesis on mechanism of action. 3° Congresso Nazionale della Società Italiana di Nutraceutica (SINUT). 20-21 September 2012, Milan, Italy.

  8. HABTEMARIAM, S. (2012). The potential of multifunctional natural products for Tteating diabetes and related diseases. Diabetes Summit 2012: Diabetes drug discovery and development - Diabetes partnering and deal making. Organised by the Global Technology Community (GTC). April 19-20, 2012. Boston, MA, USA.

  9. Corbo, F., Lovece, A., Bruno, C., Forgia, F., Fontana, S., Roselli, M., Laghezza A., Lentini G., Franchini C., HABTEMARIAM S. (2011). Antioxidant activity of Uva di Troia Canosina ad acino piccolo: comparison of different extraction methods. Symposyium of Phytochemicals in nutrition and health.  September 27-30. Giovinazzo, Bari, Italy.

  10. Roselli, M., Lentini G., HABTEMARIAM S. Valutazione dell’attività fitochimica, antiossidante e anti-α-glucosidasica di Bergenia Cordifolia. XI Sigma Aldrich Young Chemists Symposium. October 17–19. Pesaro, Italy.

  11. HABTEMARIAM, S.  (2011). Medicinal uses of Tansy (Tanacetum vulgare) for skin conditions: the scientific evidence. The 15th International Congress - PHYTOPHARM 2011. July 25-27. Norenburg, Germany.

  12. HABTEMARIAM, S. (2010). The science and art of identification of novel compounds from medicinal plants. VII International ethnobotany symposium.  Friends, the University of Peace and Foundation & Faculty of Pharmacy University of Lisbon. October 3-8.  Lisbon, Portugal.

  13. HABTEMARIAM, S. (2008). Oxidative DNA damage and cell death: search for natural protective compounds.  Analytical Tools for the Life Sciences - Oxidative DNA Damage. RSC. March 28. Research and Engineering Centre, Dublin City University, Dublin, Ireland.

  14. HABTEMARIAM, S.  (2008). Applying new science for old medicines: the quest for scientific evidence. 1st International Euro-India Conference on Holistic Medicine: (ICHM-2008): August 21-23. Kottayam, Kerala, India.

  15. Sánchez-Medina, A., Stevenson, P.C., HABTEMARIAM, S., Peña-Rodríguez, L. M., Corcoran, O., Veitch, N. C. (2008). Triterpenoid saponins from the cytotoxic root extract of Sideroxylon foetidissimum, an endemic Yucatecan medicinal plant. 7th Joint Meeting of AFERP, ASP, GA, PSE & SIF; Natural Products with Pharmaceutical, Nutraceutical, Cosmetic and Agrochemical Interest. August 3-8. Athens, Greece. Planta Medica 74, 908. Abstract

  16. Juan-Badaturuge, M., HABTEMARIAM, S., Thomas, M., Jackson, C. (2008).  Antioxidant activity of Scrophularia nodosa L., Phytochemical Society of Europe - Young Scientists Meeting. March 26-29.  Bad Harrenalb, Germany.

  17. Sánchez-Medina, A., Garcia-Sosa, K., HABTEMARIAM, S., Peña-Rodríguez, L.M. (2005). Isolation of antifungal metabolites from the root extract of Jacquinia flammmea. XI Mexican Congress of Chemistry. Morelia, Michoacán, México.

  18. Sánchez-Medina, A., Peña-Rodríguez, L.M., Karagianis, G., Waterman, P.W., HABTEMARIAM, S.  (2004). Cytotoxic saponin from the root extract of Jacquinia flammmea. International Conference of Saponins: Phytochemistry and Applications of Plant Saponins. September 8-10. Pulawy, Poland.

  19. HABTEMARIAM, S. (2003). Cytotoxicity of lignans from Comiphora erlangeriana.  Phytochemistry and biology of Lignans.  First International
    Meeting on Phytochemistry and Biology of Lignans. April 6-9. Phytochemical Society of Europe. Bornheim-Walberberg,
    Germany.  

  20. HABTEMARIAM, S. (2003). The inflammatory processes and some biological targets for drug therapy. 10th NAPRECA symposium on natural products.  September 1-4. Addis Ababa, Ethiopia.

  21. HABTEMARIAM, S. (1997). Immunosuppresive and cytotoxicity of withanolides from Discopodium penninervium. 7th Interscience World Conference on Inflammation, Antirheumatics, Analgesics, Immunomodulators.  May 19-21. Geneva, Switzerland. International Journal of Tissue Reactions: Experimental and Clinical Aspects: 19(1-2), 112.

  22. Jerusalinsky, D., Kornisiuk, E., Cerveñansky, C., HABTEMARIAM, S., Harvey A.L. (1995). MTx1 and MTx2, from green mamba venom activate M1 receptors but block other receptor subtypes. Fifth International Symposium on Neurotoxins in Neurobiology. August 31st – September 5. Mayaguez, Puerto Rico. Toxicon (Proceedings).

 

F: Patents

 

  1. HABTEMARIAM, S., Stimson, W.H., Gray, A.I., Anand, C.L. and Waterman, P.G.  Anti-psoriatic use of novel compounds (“Van-10-X compounds”). University of Strathclyde. THREE PATENTS. See details!  See also: Use of stereoisomers of calendula gylcosides for the treatment of psoriasis. Patent Number: US 6313099.

 

G: Lapsed Patents

 

  1. HABTEMARIAM, S. “INTEGRIN DEPENDENT CELL ADHESION INHIBITOR”. International PCT/GB1999/002219 (HAS BEEN LAPSED). University of Strathclyde.

  2. HABTEMARIAM, S., Burden, R., Regliniski, J., Smith, W.E. and Harvey, A.L. A UK patent application (GB 9903823.4). “Novel Schiff's base complex anti-cancer drugs”. University of Strathclyde.

 

H: News Media

 

  1. HABTEMARIAM, S. (2023). On the ranking of UK universities for world-leading quality of chemistry research: Money making through journal impact factor. Herbal Analysis Services (HAS) 2023(2):1-6. Link

  2. HABTEMARIAM, S. (2023). How Would National Survey on Academic Staff Satisfaction Drive Changes in Post-92 Universities? Assessment Based on the London Universities. Herbal Analysis Services (HAS) 2023(1):1-13. Link 

  3. HABTEMARIAM, S. (2017). Quality check on the newer UK universities. Euro Scientist. Link or PDF

  4. HABTEMARIAM, S. How many UK lecturers really are 'research active'?  Link

  5. Extensive Media coverage: Diabetes. Link

  6. Extensive Media Coverage: Herpes. Link

  Home

 

  .................We value your feedback..................

FOLLOW US ALSO ON THE FOLLOWING:

The Site Owner

Dr Habtemariam BSc, MSc, PhD, PGDipMS,  FRSC, … As a world-class scientist in the field of  natural products’ chemistry (phytochemistry) and pharmacology/ pharmacognosy, he is an author of over 300 research papers  in top-tier journals and several books. His research covers a broad area of drug discovery from natural sources, modernisation of herbal medicines, and the science of  medicinal foods and nutraceuticals ... More

 

 

Expertise

Dr Habtemariam’s expertise is based on decades of research & consultancy on pharmacological assay development in vitro, in vivo and clinical studies. His work on qualitative and quantitative analysis of medicinal products, separation/isolation of active ingredients, and structural elucidations of natural products have been based on state-of-the-art equipment including HPLC systems, NMR, mass spectrometry, etc... More

Dr Habtemariam is actively engaged  on research and outreach activities on topical issues of the UK higher education system.  This includes critical analysis of institutional culture, quality assurance on teaching & research … policy shift and emerging trends from the global higher education market perspective. Some of the articles and discussion topics are published in the news media as well as his own conversation forum - The  HAS Seminar Series.

Chromatography

Spectroscopy

Bioassays

Antimicarobial

Anticancer

Antiinflammatory

Antioxidant 

Antidiabetic

COVID-19

Neuroprotective

Plant Medicine

Pharmacognosy

Phytochemistry

Essential Oils

See How We Do It

 

Education & Training
Higher Education News

Lectures, seminars,  workshops & short courses; undergraduate, postgraduate &  postdoctoral level education and trainings ... on pharmacology &  pharmacognosy subject areas
 

Modernising the old art of traditional medicines can only happen through up-to-date scientific research

Copyright © 2006 - 2024 Herbal Analysis Services